Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 3282-3289

  Ueno, Takayuki ^a   Toi, Masakazu ^a   Saji, Hisashi ^a   Muta, Mariko ^a   Bando, Hiroko ^a   Kuroi, Katsumasa ^a   Koike, Morio ^a   Inadera, Hidekuni ^b   Matsushima, Kouji ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTIBODY; CHEMOKINE; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; EPIRUBICIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ESTROGEN RECEPTOR; FLUOROURACIL; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE RECEPTOR; PROTEINASE; TAMOXIFEN; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL MOVEMENT; CHEMOKINE CCL2; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-8; LYMPHOKINES; MACROPHAGES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033903714     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
2. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J. I., and Leonard, E. J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med., 169: 1449-1459, 1989.
3. Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., and Leonard, E. J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene. FEBS Lett., 244: 487-493, 1989.
4. Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Damme, J., Valitutti, S., Lanzavecchia, A., and Mantovani, A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol., 155: 3292-3295, 1995.
5. Roth, S. J., Carr, M. W., and Springer, T. A. C-C chemokines, but not the C-X-C chemokines interleukin 8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol., 25: 3482-3488, 1995.
6. Nakashima, E., Mukaida, N., Kubota, Y., Kuno, K., Yasumoto, K., Ichimura, F., Nakanishi, I., Miyasaka, M., and Matsushima, K. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharmacol. Res., 12: 1598-1604, 1995.
7. Zachariae, C. O., Anderson, A. O., Thompson, H. L., Appella, E., Mantovani, A., Oppenheim, J. J., and Matsushima, K. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med., 171: 2177-2182, 1990.
8. Rosenberg, S. A. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl. Cancer Inst., 88: 1635-1644, 1996.
9. Mosmann, T. R., and Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today, 17: 138-146, 1996.
10. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol., 136: 2348-2357, 1986.
11. O'Garra, A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity, 8: 275-283, 1998.
12. Beun, G. D. M., van de Velde, C. J. H., and Fleuren, G. J. T-cell based cancer immunotherapy: direct or redirected tumor-cell recognition? Immunol. Today, 15: 11-15, 1994.
13. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., and Blay, J. Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today, 18: 493-497, 1997.
14. Sallusto, F., Lanzavecchia, A., and Mackay, C. R. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today, 19: 568-574, 1998.
15. Karpus, W. J., Lukacs, N. W., Kennedy, K. J., Smith, W. S., Hurst, S. D., and Barrett, T. A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol., 158: 4129-4136, 1997.
16. Peng, L., Shu, S., and Krauss, J. C. Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells. Cancer Res., 57: 4849-4854, 1997.
17. Polverini, P. J., and Leibovich, S. J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab. Investig., 51: 635-642, 1984.
18. Sunderkötter, C., Steinbrink, K., and Goebeler, M. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
19. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56: 4625-4629, 1996.
20. Toi, M., Ueno, T., Matsumoto, H., Saji, H., Funata, N., Koike, K., and Tominaga, T. Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer. Clin. Cancer Res., 5: 1131-1137, 1999.
21. Toi, M., Harris, A. L., and Bicknell, R. Interleukin-4 is a potent mitogen for capillary endothelium. Biochem. Biophys. Res. Commun., 174: 1287-1293, 1991.
22. Fukushi, J., Morisaki, T., Shono, T., Nishie, A., Torisu, H., Ono, M., and Kuwano, M. Novel biological function of Interleukin-4: formation of tube-like structure by vascular endothelial cells in vitro and angiogenesis in vivo. Biochem. Biophys. Res. Commun., 250: 444-448, 1998.
23. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Einer, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Washington DC), 258: 1799-1801, 1992.
24. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., and Leonard, E. J. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA, 84: 9233-9237, 1987.
25. Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., and Einer, S. G. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Am. J. Pathol., 141: 1279-1284, 1992.
26. Hu, D. E. K., Hory, Y., and Fan, T. P. Interleukin-8 stimulates angiogenesis in rats. Inflammation, 17: 135-143, 1993.
27. Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Kajiyama, G., Fidler, I. J., and Tahara, E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol., 152: 93-100, 1998.
28. Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C, Iannettoni, M. D., and Strieter, R. M. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Investig., 102: 465-472, 1998.
29. Voest, E. E., Keyon, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87: 581-586, 1995.
30. Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., and Lee, W. M. F. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Investig., 15: 1441-1452, 1998.
31. Goede, V., Brogelli, L., Ziche, M., and Augustin, H. G. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer, 82: 765-770, 1999.
32. Ohta, Y., Watanabe, Y., Murakami, S., Oda, M., Hayashi, Y., Nonomura, A., Endo, Y., and Sasaki, T. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer, 76: 1041-1045, 1997.
33. Kitadai, Y., Haruma, K., Tokutomi, T., Tanaka, S., Sumii, K., Carvalho, M., Kuwabara, M., Yoshida, K., Hirai, T., Kajiyama, G., and Tahara, E. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin. Cancer Res., 4: 2195-2200, 1998.
34. Takanami, I., Tanaka, F., Hashizume, T., and Kodaira, S. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res., 17: 2811-2814, 1997.
35. Paley, P. J., Staskus, K. A., Gebhard, K., Mohanraj, D., Twiggs, L. B., Carson, L. F., and Ramakrishnan, S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (Phila.), 80: 98-106, 1997.
36. Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., and Sowa, M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (Phila.), 77: 858-863, 1996.
37. Crew, J. P., O'Brien, T., Bradbum, M., Fuggle, S., Bicknell, R., Cranston, D., and Harris, A. L. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res., 57: 5281-5285, 1997.
38. Sauter, E. R., Nesbit, M., Watson, J. C., Klein-Szanto, A., Litwin, S., and Herlyn, M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res., 5: 775-782, 1999.
39. Abdulrauf, S. I., Edvardsen, K., Ho, K. L, Yang, X. Y., Rock, J. P., and Rosenblum, M. L. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J. Neurosurg., 88: 513-520, 1998.
40. Toi, M., Gion, M., Biganzoli, E., Dittadi, R., Boracchi, P., Miceli, R., Meli, S., Mori K., Tominaga, T., and Gasparini, G. Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications. Angiogenesis, 1: 71-83, 1997.
41. Terai, M., Jibiki, T., Harada, A., Terashima, Y., Yasukawa, K., Tateno. S., Hamada, H., Oana, S., Niimi, H., and Matsushima, K. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after γ globulin treatment. J. Leukocyte Biol., 65: 566-572, 1999.
42. Chen, Z., Malhotra, P. S, Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I., Yeh, N. T., Kroog, G. S., Rudy, S., McCullagh, L., Mousa, S., Quezado, M., Herscher, L. L., and Van Waes, C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res., 5: 1369-1379, 1999.
43. Feil, C., and Augustin, H. G. Endothelial cells differentially express the CXC-chemokine receptor-4 (CXCR-4/fusin) and respond chemotactically to the CXCR-4 ligand SDF-1. Biochem. Biophys. Res. Commun., 247: 38-45, 1998.
44. Lu, B., Rutledge, B. J., and Gu, L. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med., 187: 601-608, 1998.
45. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A, Tanaka, Y., Wada, K., and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy5-fluorouridine. Cancer Chemother. Pharmacol., 32: 333-338, 1993.
46. Griffiths, L., Dachs, G. U., Bicknell, R., Harris, A. L., and Stratford, I. J. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res., 57: 570-572, 1997.
47. Dias, S., Boyd, R., and Balkwill, F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int. J. Cancer, 78: 361-365, 1998.
48. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., and Strieter, R. M. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med., 184: 981-992, 1996.
49. Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., and Hamilton, T. A. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. Immunology, 161: 927-932, 1998.
50. Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., and Tosato, G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood, 93: 1612-1621, 1999.
51. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., and Carbone, D. P. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92: 4150-4166, 1998.
52. Ito, N., Nakamura, H., Tanaka, Y., and Ohgi, S. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer (Phila.), 85: 2359-2367, 1999.
53. 1